Concepedia

Victoria Shi

VS

6

Publications

239

Citations

6

H-Index

2010

Active since

Affiliations

Enzon Pharmaceuticals (United States)(Current)

Alvin J. Siteman Cancer Center

Washington University in St. Louis

Victoria Shi is an author at Enzon Pharmaceuticals (United States) specializing in tumor biology, medicine, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2010–2023

6

Publications

6

Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection

Yixian Zhang, Zhaoxia Qu, S Kim et al. · Gene Therapy · 2010 · 66 citations · Full text

, , +19

Reduced Expression of the Androgen Receptor by Third Generation of Antisense Shows Antitumor Activity in Models of Prostate Cancer

Yixian Zhang, Stephen Castaneda, Melissa Dumble et al. · Molecular Cancer Therapeutics · 2011 · 46 citations · Full text

Downregulation of HER3 by a Novel Antisense Oligonucleotide, EZN-3920, Improves the Antitumor Activity of EGFR and HER2 Tyrosine Kinase Inhibitors in Animal Models

Yaming Wu, Yixian Zhang, Maoliang Wang et al. · Molecular Cancer Therapeutics · 2013 · 40 citations · Full text

, , +16

Diffusion tensor invasive phenotypes can predict progression-free survival in glioblastomas

Laila Mohsen, Victoria Shi, R. Jena et al. · British Journal of Neurosurgery · 2013 · 31 citations

SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production

Liyun Chen, Victoria Shi, Songyan Wang et al. · Journal of Clinical Investigation · 2023 · 29 citations · Full text

Rows per page

1–5 of 6